IP Library › Assignment 046729/0289
Patent Assignment
Reel/Frame 046729/0289

Assignment of Assignor's Interest

Recorded: 2018-08-28 Pages: 3
Assignors
HABERKORN, UWE
Executed: 2016-05-24
MIER, WALTER
Executed: 2016-05-24
Assignee
RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
GRABENGASSE 1, HEIDELBERG, 69117, GERMANY
Covered Property (1)
Labeled Inhibitors of Prostate Specific Membrane Antigen (Psma), Their Use as Imaging Agents and Pharmaceutical Agents for the Treatment of Prostate Cancer
Application: 16/114,988 →
Publication: US 2019/0060491
Related Assignments (9)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 28, 2018
From: EDER, MATTHIAS; KOPKA, KLAUS; SCHÄFER, MARTIN; BAUDER-WÜST, ULRIKE
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 046729/0111 →
Assignment of Assignor's Interest Oct 12, 2018
From: KRATOCHWIL, CLEMENS
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 047146/0613 →
Confirmation of Ownership (as Filing Relates to Compounds That Are "Derivatives") Dec 20, 2018
From: UNIVERSITY OF HEIDELBERG
To: MOLECULAR INSIGHT PHARMACEUTICAL, INC.
Reel/Frame 047972/0664 →
Declaration to Correct Assignment Record After Attempt by a Third Party to Record an Improper Assignment in Application No. 16/114,988 at Reel 047972/Frame 0664 Nov 12, 2019
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 050994/0511 →
Declaration to Correct Assignment Record Following Declaration Recorded on November 12, 2019 in Application No. 16/114,988 Feb 21, 2020
From: MOLECULAR INSIGHT PHARMACEUTICAL, INC.; UNIVERSITY OF HEIDELBERG
To: MOLECULAR INSIGHT PHARMACEUTICAL, INC.; UNIVERSITY OF HEIDELBERG
Reel/Frame 051989/0918 →
Second Declaration to Correct Assignment Record After Attempt by a Third Party to Record an Improper Assignment in Application No. 16/114,988 at Reel 051989/Frame 0918 Nov 20, 2021
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 058573/0601 →
Declaration of Brenda Herschbach Jarrell Apr 12, 2022
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 059690/0222 →
Assignment of Assignor's Interest Aug 3, 2023
From: DEUTSCHES KREBSFORSCHUNGSZENTRUM; RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
To: NOVARTIS PHARMA AG
Reel/Frame 064482/0290 →
Assignment of Assignor's Interest Aug 3, 2023
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 064482/0485 →